$BNGO As a leading life sciences company, we believe it is our duty to step up and help to stop this deadly and devastating pandemic,” said Erik Holmlin, PhD, CEO of Bionano Genomics. “Bionano’s genome imaging technology can identify variation in genome structure better than any sequencing-based method, which makes us uniquely positioned to help identify variants in the human genome that can protect against or predispose to the viral infection. We have set up studies to identify such variants around the globe, and having Bionano’s bioinformatic tools already integrated onto Rescale’s high performance computing platform enables us to scale up these studies rapidly across multiple continents.”
  • 5
  • 1